(Q43409102)

23 November 2017

title

Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109). (English)

1 reference

23 November 2017

1 reference

1 reference

1 reference

5

Naokuni Uike

1 reference

23 November 2017

Kunihiro Tsukasaki

1

1 reference

23 November 2017

Kensei Tobinai

2

1 reference

23 November 2017

Masanori Shimoyama

3

1 reference

23 November 2017

Mitsuo Kozuru

4

1 reference

23 November 2017

Yasuaki Yamada

6

1 reference

23 November 2017

Masao Tomonaga

7

1 reference

23 November 2017

Koichi Araki

8

1 reference

23 November 2017

Masaharu Kasai

9

1 reference

23 November 2017

Kiyoshi Takatsuki

10

1 reference

23 November 2017

Mitsutoshi Tara

11

1 reference

23 November 2017

Chikara Mikuni

12

1 reference

23 November 2017

Tomomitsu Hotta

13

1 reference

23 November 2017

Lymphoma Study Group of the Japan Clinical Oncology Group

14

1 reference

23 November 2017

publication date

1 February 2003

1 reference

International Journal of Hematology

23 November 2017

published in

1 reference

23 November 2017

volume

77

1 reference

23 November 2017

issue

2

1 reference

23 November 2017

page(s)

164-170

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02983215

23 November 2017

exact match

0 references

cites work

Nonparametric Estimation from Incomplete Observations

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02983215

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

21 January 2018

1 reference

12 December 2020

Eradication of virus-infected T-cells in a case of adult T-cell leukemia/lymphoma by nonmyeloablative peripheral blood stem cell transplantation with conditioning consisting of low-dose total body irradiation and pentostatin

1 reference

12 December 2020

Phase II study of carboplatin in malignant lymphoma

1 reference

12 December 2020

The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia.

1 reference

12 December 2020

A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.

1 reference

12 December 2020

Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.

1 reference

12 December 2020

Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimen.

1 reference

12 December 2020

Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50(3):481-492

1 reference

12 December 2020

Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin

1 reference

12 December 2020

An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support

1 reference

12 December 2020

Human T-lymphotropic virus type 1 infection

1 reference

12 December 2020

Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease

1 reference

12 December 2020

Pentostatin increases the acute toxicity of high dose cyclophosphamide.

1 reference

12 December 2020

A phase I study of VP-16-213 (VP, etoposide) by single and 5-day intravenous administration

1 reference

12 December 2020

Expression of P-glycoprotein in adult T-cell leukemia cells

1 reference

12 December 2020

ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study

1 reference

12 December 2020

Pentostatin therapy of T-cell lymphomas with cutaneous manifestations

1 reference

12 December 2020

EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.

1 reference

12 December 2020

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy.

1 reference

12 December 2020

Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M.

1 reference

12 December 2020

A case of ATL presenting a huge intrahepatic tumor, abated with etoposide (NK-171) therapy alone

1 reference

12 December 2020

Clinical consequences of 2'-deoxycoformycin treatment in patients with refractory adult T-cell leukaemia.

1 reference

12 December 2020

The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype

1 reference

12 December 2020

Management of adult T-cell leukaemia/lymphoma

1 reference

12 December 2020

Japan Clinical Oncology Group (JCOG)

1 reference

12 December 2020

Pentostatin in T-cell malignancies--a phase II trial of the EORTC. Leukemia Cooperative Group

1 reference

12 December 2020

Phase I study of YK-176 (2'-deoxycoformycin) in patients with adult T-cell leukemia-lymphoma. The DCF Study Group

1 reference

12 December 2020

Clinical pharmacology of deoxycoformycin

1 reference

12 December 2020

Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study

1 reference

12 December 2020

Biochemical consequences of 2'-deoxycoformycin treatment in a patient with T-cell lymphoma. Some unusual findings

1 reference

12 December 2020

Adult T-cell leukemia cells over-express the multidrug-resistance-protein (MRP) and lung-resistance-protein (LRP) genes

1 reference

12 December 2020

Successful chemotherapy with deoxycoformycin in adult T-cell lymphoma-leukaemia

1 reference

12 December 2020

2'-Deoxycoformycin therapy in adult T-cell leukemia/lymphoma

1 reference

12 December 2020

Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).

1 reference

12 December 2020

Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia.

1 reference

12 December 2020

Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02983215

1 reference

23 November 2017

1 reference